FRESENIUS MEDICAL CARE AG (FME.DE) Stock Fundamental Analysis
Europe - FRA:FME - DE0005785802 - Common Stock
39.74 EUR
+0.1 (+0.25%)
We assign a fundamental rating of 5 out of 10 to FME. FME was compared to 31 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of FME get a neutral evaluation. Nothing too spectacular is happening here. A decent growth rate in combination with a cheap valuation! Better keep an eye on FME.
1. Profitability
1.1 Basic Checks
In the past year FME was profitable.
FME had a positive operating cash flow in the past year.
In the past 5 years FME has always been profitable.
In the past 5 years FME always reported a positive cash flow from operatings.
1.2 Ratios
FME has a Return On Assets (2.10%) which is in line with its industry peers.
FME has a Return On Equity (4.95%) which is in line with its industry peers.
FME has a Return On Invested Capital (3.84%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for FME is below the industry average of 6.75%.
The 3 year average ROIC (3.14%) for FME is below the current ROIC(3.84%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.1% | ||
| ROE | 4.95% | ||
| ROIC | 3.84% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
1.3 Margins
The Profit Margin of FME (3.36%) is better than 61.29% of its industry peers.
In the last couple of years the Profit Margin of FME has declined.
FME has a Operating Margin (7.15%) which is comparable to the rest of the industry.
FME's Operating Margin has declined in the last couple of years.
FME has a Gross Margin of 24.67%. This is comparable to the rest of the industry: FME outperforms 51.61% of its industry peers.
In the last couple of years the Gross Margin of FME has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.15% | ||
| PM (TTM) | 3.36% | ||
| GM | 24.67% |
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FME is destroying value.
The number of shares outstanding for FME remains at a similar level compared to 1 year ago.
Compared to 5 years ago, FME has less shares outstanding
The debt/assets ratio for FME has been reduced compared to a year ago.
2.2 Solvency
FME has an Altman-Z score of 2.15. This is not the best score and indicates that FME is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of FME (2.15) is better than 61.29% of its industry peers.
FME has a debt to FCF ratio of 5.47. This is a neutral value as FME would need 5.47 years to pay back of all of its debts.
FME has a better Debt to FCF ratio (5.47) than 70.97% of its industry peers.
A Debt/Equity ratio of 0.71 indicates that FME is somewhat dependend on debt financing.
FME has a better Debt to Equity ratio (0.71) than 67.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.47 | ||
| Altman-Z | 2.15 |
ROIC/WACC0.68
WACC5.68%
2.3 Liquidity
FME has a Current Ratio of 1.44. This is a normal value and indicates that FME is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.44, FME is in the better half of the industry, outperforming 74.19% of the companies in the same industry.
FME has a Quick Ratio of 1.08. This is a normal value and indicates that FME is financially healthy and should not expect problems in meeting its short term obligations.
FME has a Quick ratio of 1.08. This is in the better half of the industry: FME outperforms 67.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.08 |
3. Growth
3.1 Past
FME shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.08%.
FME shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.43% yearly.
Looking at the last year, FME shows a decrease in Revenue. The Revenue has decreased by -0.61% in the last year.
FME shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.04% yearly.
EPS 1Y (TTM)-0.08%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%-32.02%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%4.49%
3.2 Future
FME is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.70% yearly.
The Revenue is expected to grow by 3.96% on average over the next years.
EPS Next Y18.38%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
EPS Next 5Y13.7%
Revenue Next Year1.2%
Revenue Next 2Y2.1%
Revenue Next 3Y2.99%
Revenue Next 5Y3.96%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 12.34 indicates a correct valuation of FME.
Based on the Price/Earnings ratio, FME is valued cheaply inside the industry as 80.65% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 25.51. FME is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 9.59 indicates a reasonable valuation of FME.
90.32% of the companies in the same industry are more expensive than FME, based on the Price/Forward Earnings ratio.
FME is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.98, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.34 | ||
| Fwd PE | 9.59 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as FME.
67.74% of the companies in the same industry are more expensive than FME, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.57 | ||
| EV/EBITDA | 10.5 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
FME's earnings are expected to grow with 13.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.67
PEG (5Y)N/A
EPS Next 2Y12.9%
EPS Next 3Y13.44%
5. Dividend
5.1 Amount
FME has a Yearly Dividend Yield of 3.51%.
Compared to an average industry Dividend Yield of 2.44, FME pays a better dividend. On top of this FME pays more dividend than 96.77% of the companies listed in the same industry.
FME's Dividend Yield is a higher than the S&P500 average which is at 2.44.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.51% |
5.2 History
The dividend of FME has a limited annual growth rate of 0.31%.
Dividend Growth(5Y)0.31%
Div Incr Years1
Div Non Decr Years2
5.3 Sustainability
64.37% of the earnings are spent on dividend by FME. This is not a sustainable payout ratio.
The dividend of FME is growing, but earnings are growing more, so the dividend growth is sustainable.
DP64.37%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
FRA:FME (11/19/2025, 11:56:07 AM)
39.74
+0.1 (+0.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners43.16%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.32B
Revenue(TTM)19.34B
Net Income(TTM)656.42M
Analysts65.6
Price Target49.48 (24.51%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.51% |
Yearly Dividend1.19
Dividend Growth(5Y)0.31%
DP64.37%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.03%
Min EPS beat(2)14.89%
Max EPS beat(2)27.17%
EPS beat(4)4
Avg EPS beat(4)20.72%
Min EPS beat(4)14.89%
Max EPS beat(4)27.17%
EPS beat(8)7
Avg EPS beat(8)15.78%
EPS beat(12)10
Avg EPS beat(12)13.92%
EPS beat(16)12
Avg EPS beat(16)10.11%
Revenue beat(2)1
Avg Revenue beat(2)-0.3%
Min Revenue beat(2)-3.33%
Max Revenue beat(2)2.74%
Revenue beat(4)2
Avg Revenue beat(4)0.26%
Min Revenue beat(4)-4.4%
Max Revenue beat(4)6.05%
Revenue beat(8)3
Avg Revenue beat(8)-0.45%
Revenue beat(12)5
Avg Revenue beat(12)-0.49%
Revenue beat(16)6
Avg Revenue beat(16)-0.51%
PT rev (1m)-1.72%
PT rev (3m)-4.31%
EPS NQ rev (1m)8.29%
EPS NQ rev (3m)6.47%
EPS NY rev (1m)0.52%
EPS NY rev (3m)3.82%
Revenue NQ rev (1m)0.65%
Revenue NQ rev (3m)0.26%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.34 | ||
| Fwd PE | 9.59 | ||
| P/S | 1.19 | ||
| P/FCF | 11.57 | ||
| P/OCF | 8.47 | ||
| P/B | 1.76 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.5 |
EPS(TTM)3.22
EY8.1%
EPS(NY)4.14
Fwd EY10.42%
FCF(TTM)3.43
FCFY8.64%
OCF(TTM)4.69
OCFY11.81%
SpS33.26
BVpS22.61
TBVpS-2.73
PEG (NY)0.67
PEG (5Y)N/A
Graham Number40.48
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.1% | ||
| ROE | 4.95% | ||
| ROCE | 5.44% | ||
| ROIC | 3.84% | ||
| ROICexc | 4.19% | ||
| ROICexgc | 11.45% | ||
| OM | 7.15% | ||
| PM (TTM) | 3.36% | ||
| GM | 24.67% | ||
| FCFM | 10.32% |
ROA(3y)1.65%
ROA(5y)2.29%
ROE(3y)4.06%
ROE(5y)6.04%
ROIC(3y)3.14%
ROIC(5y)4%
ROICexc(3y)3.31%
ROICexc(5y)4.22%
ROICexgc(3y)8.52%
ROICexgc(5y)10.56%
ROCE(3y)4.51%
ROCE(5y)5.77%
ROICexgc growth 3Y-7.67%
ROICexgc growth 5Y-10.05%
ROICexc growth 3Y-10.35%
ROICexc growth 5Y-11.48%
OM growth 3Y-13.44%
OM growth 5Y-12.95%
PM growth 3Y-20.33%
PM growth 5Y-16.53%
GM growth 3Y-3.16%
GM growth 5Y-4.44%
F-Score6
Asset Turnover0.62
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.71 | ||
| Debt/FCF | 5.47 | ||
| Debt/EBITDA | 3.14 | ||
| Cap/Depr | 45.83% | ||
| Cap/Sales | 3.79% | ||
| Interest Coverage | 3.82 | ||
| Cash Conversion | 91.56% | ||
| Profit Quality | 307% | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.08 | ||
| Altman-Z | 2.15 |
F-Score6
WACC5.68%
ROIC/WACC0.68
Cap/Depr(3y)41.32%
Cap/Depr(5y)47.87%
Cap/Sales(3y)3.79%
Cap/Sales(5y)4.49%
Profit Quality(3y)300.36%
Profit Quality(5y)267.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.08%
EPS 3Y-1.97%
EPS 5Y-6.43%
EPS Q2Q%-32.02%
EPS Next Y18.38%
EPS Next 2Y12.9%
EPS Next 3Y13.44%
EPS Next 5Y13.7%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y3.15%
Revenue growth 5Y2.04%
Sales Q2Q%4.49%
Revenue Next Year1.2%
Revenue Next 2Y2.1%
Revenue Next 3Y2.99%
Revenue Next 5Y3.96%
EBIT growth 1Y2.71%
EBIT growth 3Y-10.72%
EBIT growth 5Y-11.17%
EBIT Next Year96.66%
EBIT Next 3Y30.5%
EBIT Next 5Y19.09%
FCF growth 1Y14.07%
FCF growth 3Y1.25%
FCF growth 5Y3.45%
OCF growth 1Y14.41%
OCF growth 3Y-1.4%
OCF growth 5Y-1.45%
FRESENIUS MEDICAL CARE AG / FME.DE FAQ
What is the fundamental rating for FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.
What is the valuation status of FRESENIUS MEDICAL CARE AG (FME.DE) stock?
ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Undervalued.
What is the profitability of FME stock?
FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for FME stock?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE AG (FME.DE) is 12.34 and the Price/Book (PB) ratio is 1.76.
Can you provide the dividend sustainability for FME stock?
The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 6 / 10 and the dividend payout ratio is 64.37%.